Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This update does not change the study information shown on the page.
    Difference
    0.0%
    Check dated 2026-03-18T22:56:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T20:02:31.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new site revision label Revision: v3.4.2 was added, and older revision notices (Revision: v3.4.1) along with a government-funding notice were removed. These are administrative changes that do not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:33:36.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a government funding status notice about potential delays and the NIH open status. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:36:41.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page adds a glossary display option and updates QC metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T21:12:20.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Locations section reorganized to list study sites by state under a single Locations heading (Florida, Massachusetts, New York, Tennessee, Texas, Virginia), replacing the former per-state 'X Locations' subsections. This clarifies where the trial is conducted and makes site information more accessible to potential participants.
    Difference
    0.6%
    Check dated 2025-12-22T22:55:44.000Z thumbnail image

Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.